Search This Blog

Monday, April 27, 2026

Veradermics' VDPHL01 Phase 2/3 Part A data show strong hair-growth efficacy

 

Veradermics' VDPHL01 Phase 2/3 Part A data show strong hair-growth efficacy, no treatment-related cardiovascular events in male pattern hair loss

  • VDPHL01 met all primary and key secondary endpoints with robust hair growth and favorable safety in Study 302 Part A.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)